This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Headache
  • /
  • The 5-HT1F receptor agonist lasmiditan as a potent...

The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials.

Read time: 1 mins
Published:1st Jun 2012
Author: Tfelt-Hansen PC, Olesen J.
Availability: Free full text
Ref.:J Headache Pain. 2012;13(4):271-5.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest